Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
INACTIVE
Global HQ
Cambridge, United States
Countries of investment
  • USA
Investment stages
  • Seed
  • Series A
Industries
  • Fintech
  • AI
  • Blockchain
About
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

Baxalta Ventures’ investment thesis centers on identifying and investing in early stage biotech and healthcare companies with promising therapeutic innovations. The firm targets startups working on advanced treatments for rare diseases, oncology, and other critical medical areas. By offering both capital and strategic support, Baxalta Ventures aims to drive the development of transformative therapies and achieve significant advancements in the healthcare industry.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Focused on early-stage investments in technology and healthcare sectors across North America and Europe. With deep experience in leading over 50 deals, the firm emphasizes a hands-on approach that drives operational efficiency. Specializes in identifying high-potential startups, resulting in multiple successful exits. Recognized for a collaborative investment style that fosters strong partnerships with founders for sustainable growth.
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp